Correlative analyses between tissue-based hypoxia biomarkers and hypoxia PET imaging in head and neck cancer patients during radiochemotherapy—results from a prospective trial-Reference-Cited by-同舟云学术

Correlative analyses between tissue-based hypoxia biomarkers and hypoxia PET imaging in head and neck cancer patients during radiochemotherapy—results from a prospective trial

Published:2019-12-07 Issue:5 Volume:47 Page:1046-1055
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Nicolay Nils H.^ORCID,Wiedenmann Nicole,Mix Michael,Weber Wolfgang A.,Werner Martin,Grosu Anca L.,Kayser Gian

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-019-04598-9.pdf

Reference49 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

2. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354(6):567–78.

3. Blanchard P, Baujat B, Holostenco V, Bourredjem A, Baey C, Bourhis J. Pignon JP, group M-CC: Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. Radiother Oncol. 2011;100(1):33–40.

4. Baumann R, Depping R, Delaperriere M, Dunst J. Targeting hypoxia to overcome radiation resistance in head & neck cancers: real challenge or clinical fairytale? Expert Rev Anticancer Ther. 2016;16(7):751–8.

5. Zips D, Zophel K, Abolmaali N, Perrin R, Abramyuk A, Haase R, et al. Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer. Radiother Oncol. 2012;105(1):21–8.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rethinking the potential role of dose painting in personalized ultra-fractionated stereotactic adaptive radiotherapy;Frontiers in Oncology;2024-03-20

2. Is there a role for [18F]-FMISO PET to guide dose adaptive radiotherapy in head and neck cancer? A review of the literature;Clinical and Translational Imaging;2024-01-23

3. PET/MR Imaging in Head and Neck Cancer;Magnetic Resonance Imaging Clinics of North America;2023-11

4. Is there a role for [18F]FMISO PET to guide dose adaptive radiotherapy in head and neck cancer? A review of the literature.;2023-10-12

5. 18F‐FMISO PET‐guided dose escalation with multifield optimization intensity‐modulated proton therapy in nasopharyngeal carcinoma;Asia-Pacific Journal of Clinical Oncology;2023-05-08